(EMAILWIRE.COM, July 10, 2019 ) The report "Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast", the Global Viral Inactivation Market is expected to grow at a CAGR of 12.3% to reach $ 573.0 million

Download PDF (Viral Inactivation Market): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017

Viral Inactivation Market segmentation:

· Based on Method

· Based on Product

· Based on Application

· Based on End Users

· Based on Geography.

The Major Players Operating in the Viral Inactivation Market:

Acquisition and expansions were the two most important growth strategies employed the key players in this market.

Major players in the Viral Inactivation Market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).

SGS Life Science Services completed the expansion of biologics testing facility in Glasgow, UK. The 500 square meter expansion, with a staff of 45 personnel will offer a full range of validated bioanalytical methods for testing of biologics, viral vaccines, and gene & cell therapies.

Read a Press Release on “Viral Inactivation Market” https://www.marketsandmarkets.com/PressReleases/viral-inactivation.asp

Geographical Detailed Analysis for Viral Inactivation Market:

The Geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (Row).

The North America segment is further divided into Canada and the U.S. Asia segment is further divided into China, Japan, India, and Rest of Asia.